Analyst Ratings for IMS Health Holdings Inc (IMS)Updated: 2016-10-01
IMS was given price targets by several analysts. The highest price target was 34, which equates to a potential upside of 8.49 percent. The most pessimistic price target was 25, which equates to a potential downside of -20.23 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is 2.78 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.91 percent.
People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 0 analysts that revised their FY estimates downwards.
Analysts estimate earnings of IMS to grow at a rate of 277.44 percent. Another measure frequently examined by investors is the PEG ratio. A lower PEG ratio is favorable, as that can indicate whether the high price level of a stock is warranted by high growth. PEG ratios below 1 are often considered desirable, though it could be better to see where the ratio stands relative to peers in the industry. IMS has a PEG ratio of 0.27.
In the last 52-weeks, IMS has achieved a high of 31.59 and a low of 22.36. The current market price is above the trailing year's low by 40.16 percent, and 0.79 percent lower than its 52-week high. IMS has a P/E ratio of 75.45. Investors typically compare the P/E ratio to a company's peers in the industry. The IMS value stock report compares IMS to some of its peers using value stock charts. The stock has a market capitalization of $10.59 billion. IMS is estimated to release their earnings results for the quarter on 2016-10-27, days from today.